| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 703547 | Null | 0.0026598958355165 | -0.27487714 |
| NSC 618262 | Null | 0.00289834947687855 | -0.087130014 |
| NSC 692597 | Null | 0.00289834947687855 | 0.13397188 |
| NSC 363787 | Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- | 0.00334162892839397 | -0.19625284 |
| NSC 625502 | Antimony, chlorobis(4-morpholinecarbodithioato-S,S')-, | 0.00334162892839397 | -0.14673781 |
| NSC 639501 | Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride | 0.00334162892839397 | -0.26346565 |
| NSC 668259 | Null | 0.00334162892839397 | -0.37990702 |
| NSC 668264 | Null | 0.00334162892839397 | -0.31243999 |
| NSC 688074 | 16,24-Cyclo-13,14-secoergost-2-ene-18,26-dioic acid, 5-chloro-14,17:14,27-diepoxy-6,13,20,22-tetrahydroxy-1,15-dioxo-, .gamma.-lactone .delta.-lactone | 0.00334162892839397 | -0.1040037 |
| NSC 694001 | 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester | 0.00337662564965909 | -0.20484747 |